I wrote on another thread
here that I believe that this Fluge & Mella study is showing that the PI3K/Akt/mTOR signaling pathway is being inhibited (or not properly activated). I'm not able to find any other way that SIRT4 expression can be significantly increased, as found in the study, and mTORC1 not be inhibited and everything still make sense. (mTORC1 is one of two mTOR enzyme complexes and is downstream in the signaling pathway.)
A properly activated (unihibited) mTORC1 represses SIRT4. Too much SIRT4 inhibits the pyruvate dehydrogenase (PDH) complex (
reference); it inhibits fatty acid oxidation (
reference); and it inhibits glutamate dehydrogenase (GDH) which converts glutamate to alpha-ketoglutarate (
reference). These inhibitions could contribute to exertion intolerance, exhaustion, PEM, hypoglycemia, and/or glutamate excitotoxicity.
There is also a direct correlation between aldosterone levels, which can be inexplicably low in ME/CFS, and the degree of activation of the Akt/mTOR pathway. (
Reference)
Also, fludrocortisone (Florinef), which is sometimes useful in ME/CFS - even in the absence of low aldosterone levels, can help activate the Akt/mTOR pathway. (
Reference) So this fits as well.
Interestingly, an inhibited (or unactivated) mTORC1 can cause an impaired ability to concentrate urine. (
Reference) So we may finally have an explanation for that common secondary ME/CFS symptom.
Note also that inhibition of the PI3K/Akt/mTOR pathway leads to an upregulation of the pyruvate dehydrogenase kinases (PDKs) (
reference), which was also found in the Fluge & Mella study.
So it seems to me that in ME/CFS there may be a dysregulation in the pathway involving mTORC1 that is essentially opposite to that found in most cancers, where mTORC1 is over-activated.
[There's also an additional signaling pathway that leads to mTORC1, the ERK pathway, that is apparently parallel and additive with the Akt pathway. (
Reference) I haven't looked at this pathway yet.]
What might help if mTORC1 is in fact inhibited? See my next post.